Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APTO | AMGN | BMY | GILD | VRTX |
| Company | Aptose Bioscns | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.2507 | 261.10 | 57.65 | 93.43 | 405.26 |
| High | 0.2634 | 261.65 | 58.00 | 94.10 | 408.00 |
| Low | 0.2507 | 260.80 | 57.62 | 93.43 | 405.00 |
| Last | 0.2312 | 262.57 | 58.19 | 94.23 | 409.01 |
| Change | -0.0195 | -0.61 | +0.19 | -0.18 | -1.64 |
| % Change | -7.78% | -0.23% | +0.33% | -0.19% | -0.40% |
| Volume | 253,608 | 34,603 | 85,817 | 109,244 | 25,277 |
| 20-Day Average Volume | 19,034,686 | 3,902,650 | 10,901,487 | 6,822,527 | 1,825,865 |
| Previous Close | 0.2507 | 263.18 | 58.00 | 94.41 | 410.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2052 | 270.24 | 57.76 | 92.54 | 449.18 |
| 20-Day Raw Stochastic | 40.09% | 26.90% | 54.87% | 90.55% | 33.26% |
| 20-Day Relative Strength | 50.01% | 31.77% | 54.02% | 58.30% | 35.06% |
| Weighted Alpha | -85.54 | -15.95 | +20.65 | +26.42 | -7.12 |
| Today's Opinion | 80% Sell | 88% Sell | 96% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 80% Sell | 88% Sell | 96% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Buy | 96% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +51.59% since 12/19/24 | +0.10% since 12/19/24 | +2.68% since 12/19/24 | +3.34% since 12/19/24 | -8.23% since 12/18/24 |
| Low | 0.2106 on 12/20/24 | 260.80 on 12/27/24 | 56.08 on 12/20/24 | 90.71 on 12/20/24 | 377.85 on 12/19/24 |
| High | 0.3895 on 12/20/24 | 269.61 on 12/20/24 | 58.07 on 12/26/24 | 94.55 on 12/26/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | +44.13% since 11/27/24 | -6.64% since 11/27/24 | -2.46% since 11/27/24 | +1.86% since 11/27/24 | -12.08% since 11/26/24 |
| Low | 0.1700 on 12/19/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 0.3895 on 12/20/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -36.33% since 09/27/24 | -18.97% since 09/27/24 | +13.55% since 09/27/24 | +12.58% since 09/27/24 | -11.34% since 09/26/24 |
| Low | 0.1300 on 11/22/24 | 253.30 on 12/19/24 | 51.03 on 09/30/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 0.4162 on 11/11/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -65.60% since 06/27/24 | -16.65% since 06/27/24 | +39.27% since 06/27/24 | +36.76% since 06/27/24 | -13.36% since 06/26/24 |
| Low | 0.1300 on 11/22/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 0.8100 on 07/03/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 15,087 | 141,467,936 | 117,634,272 | 117,659,984 | 105,754,280 |
| Shares Outstanding, K | 60,181 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -51,210,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -6,950,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.06 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/08/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/14/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.76 | 49.37 | 21.21 | 0.00 |